Skip to main content
. 2020 Jul 23;25(6):e752–e761. doi: 10.4317/medoral.23777

Table 3. Association among ALDH1, E-CAD, N-CAD immunoexpression in tumor areas and clinical parameters.

graphic file with name medoral-25-e752-t003.jpg